Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

800465

registered interest
date	04/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Fractures
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether they intend to ensure that all NHS users over 50 years old have access to Fracture Liaison Services to identify the link between any fracture and the bone health of the patient.
tabling member printed	Baroness Quin
uin	HL3852
answer	answer is ministerial correction date of answer 14/12/2017 answer text <p>Fracture liaison services (FLS) provide secondary prevention for fragility fractures. These services identify patients in secondary and/or primary care who have suffered a fragility fracture and assess the patient’s risk of future fragility fracture in a timely fashion. A FLS then provides advice and/or therapy to reduce that risk.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) evidence based guideline <em>Osteoporosis: assessing the risk of fragility fracture</em>, updated in February 2017, sets out best practice on management of fracture risk in patients with osteoporosis. A copy of the guideline is attached. The guidance recommends that clinicians consider assessment of fracture risk in all women aged 65 years and over and all men aged 75 years and over. Women aged less than 65 years and men aged less than 75 years should be considered for assessment in the presence of certain risk factors, such as a family history of hip fracture or low body mass index.</p><p> </p><p>Regarding bone density scanning, NICE recommends it be considered after patients have first been assessed using a validated risk assessment tool, such as FRAX, which clinicians can use to evaluate the 10-year probability of bone fracture risk in patient. The guidance also recommends other circumstances where bone density scanning should be considered, including for patients who are to undergo treatment which may affect bone density, such as certain treatments for breast or prostate cancer.</p><p> </p><p> </p> answering member printed Lord O'Shaughnessy grouped question UIN HL3853 question first answered 14/12/2017 15:01:14 answering member 4545 label Biography information for Lord O'Shaughnessy attachment 1 file name osteoporosis-assessing-the-risk-of-fragility-fracture-pdf-35109574194373.pdf title Osteoporosis
tabling member	518 label Biography information for Baroness Quin

800466

registered interest
date	04/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Osteoporosis
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether they intend to ensure that women over 60 years old are routinely offered bone density scans to ascertain bone health.
tabling member printed	Baroness Quin
uin	HL3853
answer	answer is ministerial correction date of answer 14/12/2017 answer text <p>Fracture liaison services (FLS) provide secondary prevention for fragility fractures. These services identify patients in secondary and/or primary care who have suffered a fragility fracture and assess the patient’s risk of future fragility fracture in a timely fashion. A FLS then provides advice and/or therapy to reduce that risk.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) evidence based guideline <em>Osteoporosis: assessing the risk of fragility fracture</em>, updated in February 2017, sets out best practice on management of fracture risk in patients with osteoporosis. A copy of the guideline is attached. The guidance recommends that clinicians consider assessment of fracture risk in all women aged 65 years and over and all men aged 75 years and over. Women aged less than 65 years and men aged less than 75 years should be considered for assessment in the presence of certain risk factors, such as a family history of hip fracture or low body mass index.</p><p> </p><p>Regarding bone density scanning, NICE recommends it be considered after patients have first been assessed using a validated risk assessment tool, such as FRAX, which clinicians can use to evaluate the 10-year probability of bone fracture risk in patient. The guidance also recommends other circumstances where bone density scanning should be considered, including for patients who are to undergo treatment which may affect bone density, such as certain treatments for breast or prostate cancer.</p><p> </p><p> </p> answering member printed Lord O'Shaughnessy grouped question UIN HL3852 question first answered 14/12/2017 15:01:14 answering member 4545 label Biography information for Lord O'Shaughnessy attachment 1 file name osteoporosis-assessing-the-risk-of-fragility-fracture-pdf-35109574194373.pdf title Osteoporosis
tabling member	518 label Biography information for Baroness Quin

450944

registered interest
date	08/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer: Screening
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what the average waiting time is for a result to be given of a DEXA bone density scan in each NHS region in England; and what assessment they have made of the average waiting time for such results in (1) Scotland, and (2) Wales.
tabling member printed	Baroness Quin
uin	HL5970
answer	answer is ministerial correction date of answer 11/02/2016 answer text <p>Genomics England has set an objective to deliver 8,000 clinical reports by the end of 2016. The precise details of the reports from the pilot and main phases will become clearer once the phenotypic data is collected and linked to the genome data.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 11/02/2016 13:19:44 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	518 label Biography information for Baroness Quin

451119

registered interest
date	08/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Osteoporosis
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what is the average waiting time for a result to be given of a DEXA bone density scan in each NHS region in England; and what assessment they have made of the average waiting time for such results in (1) Scotland, and (2) Wales.
tabling member printed	Baroness Quin
uin	HL5985
answer	answer is ministerial correction date of answer 11/02/2016 answer text <p>Data are not collected on the average waiting time for a result to be given for a dual energy X-ray absorptiometry (DEXA) scan. Data are collected on the average waiting time from referral to test, and these are shown in the following table for the four NHS England commissioning regions for most recent period, which is November 2015. Health is a devolved matter in Scotland and Wales.</p><p> </p><p>Table: average median waiting times in weeks for a DEXA scan from referral by NHS England commissioning region, November 2015</p><p> </p><table><tbody><tr><td><p>Region</p></td><td><p>Number of weeks</p></td></tr><tr><td><p>North of England</p></td><td><p>2.1</p></td></tr><tr><td><p>Midlands and East of England</p></td><td><p>1.7</p></td></tr><tr><td><p>London</p></td><td><p>1.8</p></td></tr><tr><td><p>South of England</p></td><td><p>1.8</p></td></tr><tr><td><p>England</p></td><td><p>1.9</p></td></tr></tbody></table><p> </p><p><strong> </strong></p> answering member printed Lord Prior of Brampton question first answered 11/02/2016 13:18:56 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	518 label Biography information for Baroness Quin

451120

registered interest
date	08/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health Services: Foreign Nationals
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what consultations took place with the government of New Zealand prior to their decision to introduce new charges for New Zealand citizens for health and dental treatment in the UK from 6 April.
tabling member printed	Baroness Quin
uin	HL5986
answer	answer is ministerial correction date of answer 22/02/2016 answer text <p>On 6 April 2015 the United Kingdom introduced an immigration health surcharge for non-European Economic Area nationals who come to the UK to temporarily reside for a period of over six months. At the time New Zealand nationals were granted a temporary exemption and we entered into a series of discussions with the New Zealand Government on the introduction of the surcharge for its nationals. The Secretary of State for Health wrote to the New Zealand High Commissioner confirming introduction of the surcharge on 17 December 2015. Introduction of the surcharge for New Zealand nationals was publicly announced by the Home Office on 4 February 2016 and subject to Parliamentary approval, it will come into effect from 6 April 2016.</p> answering member printed Lord Prior of Brampton question first answered 22/02/2016 17:05:12 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	518 label Biography information for Baroness Quin